12:00 AM
 | 
Dec 09, 2013
 |  BC Week In Review  |  Company News  |  Deals

Merrimack, Actavis deal

Merrimack said it will use its nanoliposomal technology to develop and manufacture undisclosed products for Actavis, the first of which will be a...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >